trial · primary record
Alpelisib
Advanced Malignant Solid Neoplasm
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 2900 |
| Primary completion | 2030-07-01 |
| Primary endpoint | Accrual of patients to ComboMATCH treatment trials |
| Registry ID | NCT05564377 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:34.376Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05564377
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.